Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Launched by M.D. ANDERSON CANCER CENTER · Jul 12, 2024
Trial Information
Current as of May 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patients with advanced thyroid cancer, specifically anaplastic thyroid cancer or poorly differentiated thyroid cancer, are managing their treatments in the real world. The researchers want to understand the challenges patients face in accessing these treatments and how well they respond to commonly available medications outside of a controlled study environment.
To participate, you need to be an adult aged 18 or older diagnosed with either anaplastic or poorly differentiated thyroid cancer. If you qualify and decide to join, you’ll be part of a registry that collects information about your treatment experiences and outcomes. This study aims to provide valuable insights that could help improve care for future patients with this type of cancer. If you have more questions or are interested in learning how to participate, please reach out to the study team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients aged 18 years or older with anaplastic thyroid cancer or poorly differentiated thyroid cancer as their clinical and/ or histological diagnosis will be included.
- Exclusion Criteria:
- • Patients who do not have anaplastic thyroid cancer or poorly differentiated thyroid cancer on their tumor tissue would be excluded.
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Priyanka C Iyer, MBBS
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported